The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19
Summary: COVID-19 disproportionately affects older people, with likelihood of severe complications and death mirroring that of other age-associated diseases. Inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) has been shown to delay or reverse many age-related phenotypes, including...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-02-01
|
| Series: | The Lancet. Healthy Longevity |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666756820300684 |